The short version
Only one company currently supplies this market — there is no backup if it stumbles.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
SODIUM CHLORIDE, SODIUM GLUCONATE, SODIUM ACETATE, POTASSIUM CHLORIDE, MAGNESIUM CHLORIDE, SODIUM PHOSPHATE, DIBASIC, and POTASSIUM PHOSPHATE · SODIUM CHLORIDE .53 g/100mL; SODIUM GLUCONATE .5 g/100mL; SODIUM ACETATE .37 g/100mL; POTASSIUM CHLORIDE .037 g/100mL; MAGNESIUM CHLORIDE .03 g/100mL; SODIUM PHOSPHATE, DIBASIC .012 g/100mL; POTASSIUM PHOSPHATE, MONOBASIC .00082 g/100mL · Injection, Solution · Intravenous · B. Braun Medical Inc.
NDC 00264-7707-00 · 12 CONTAINER in 1 CASE / 1000 mL in 1 CONTAINER · NDA · View full market →
Only one company currently supplies this market — there is no backup if it stumbles.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Negotiated 30-day point-of-sale unit prices and formulary terms aggregated across every unsuppressed Part D and MA-PD plan for the quarter shown. Point of sale means gross of confidential rebates. CMS publishes one representative NDC per drug concept (RxCUI) rather than every package, so these figures come from CMS's representative package for the same drug — matched on generic name, strength, and dosage form. Estimated from MedPAC's program-wide rebate aggregates (June 2023: DIR = 29% of gross Part D spending; brand rebates ≈ 25–40% of gross, generics minimal). Actual rebates are confidential and vary widely by drug — this is a range, not a fact about this drug.
Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.
*No drug-level rebate is public — the estimate applies MedPAC's program-wide brand rebate range to this drug's gross price. Tracked here for 10 quarters since 2024.
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Manufacturer list price as filed — not what pharmacies actually pay after discounts.
Not scored — fragility is computed for NADAC-priced NDCs.
There's no legal definition — it meets 1 of 6 public criteria. Why that matters →
No FDA shortage reports for this drug or its presentations.
No enforcement reports list this package NDC.
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| B. Braun Medical Inc. | SODIUM CHLORIDE .53 g/100mL; SODIUM GLUCONATE .5 g/100mL; SODIUM ACETATE .37 g/100mL; POTASSIUM CHLORIDE .037 g/100mL; MAGNESIUM CHLORIDE .03 g/100mL; SODIUM PHOSPHATE, DIBASIC .012 g/100mL; POTASSIUM PHOSPHATE, MONOBASIC .00082 g/100mL | Aug 26, 2026 | Sep 2, 2026 |
| B. Braun Medical Inc. | SODIUM CHLORIDE .03 g/100mL; SODIUM GLUCONATE .037 g/100mL; SODIUM ACETATE .00082 g/100mL; POTASSIUM CHLORIDE .37 g/100mL; MAGNESIUM CHLORIDE .53 g/100mL; SODIUM PHOSPHATE, DIBASIC .5 g/100mL; POTASSIUM PHOSPHATE, MONOBASIC .012 g/100mL | Jul 22, 2026 | Aug 19, 2026 |
| B. Braun Medical Inc. | MAGNESIUM CHLORIDE .03 g/100mL; POTASSIUM CHLORIDE .037 g/100mL; POTASSIUM PHOSPHATE, MONOBASIC .00082 g/100mL; SODIUM ACETATE .37 g/100mL; SODIUM CHLORIDE .53 g/100mL; SODIUM GLUCONATE .5 g/100mL; SODIUM PHOSPHATE, DIBASIC .012 g/100mL | Jul 15, 2026 | Jul 15, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
DrugDashboards, "Isolyte S pH 7.4 — NDC 00264-7707-00," retrieved September 3, 2026, https://drugdashboards.com/drug/00264770700.
Free to cite with attribution — see how the data is put together.